Disney CFO Christine McCarthy To Step Down — Kevin Lansberry To Take Interim Charge

Christine McCarthy, Walt Disney Co’s (NYSE:DIS) senior executive vice-president and chief financial officer, will be stepping down from…

Christine McCarthy, Walt Disney Co’s (NYSE:DIS) senior executive vice-president and chief financial officer, will be stepping down from her role and taking a family medical leave of absence, the company announced on Thursday.

Veteran Disney executive Kevin Lansberry will serve as the company’s Interim CFO, effective July 1, it said. As Interim CFO, Lansberry will assume oversight of the company’s worldwide finance organization.

Also Read: Best Penny Stocks

McCarthy will continue as a strategic advisor to Disney during her leave and will assist with the process of identifying and onboarding a long-term successor.

Tenure: McCarthy joined Disney in 2000 as Treasurer and became Chief Financial Officer in 2015. “I am immensely grateful for the opportunity Bob provided me to serve as CFO of this iconic company and am proud of the work my talented team has done to position Disney to capitalize on the business possibilities that lie ahead,” she said according to the statement.

Disney Chief Executive Officer Bog Iger said what he admires most about McCarthy is the “generous mentorship she has provided to so many of her colleagues over the years, including countless women.” “She has opened doors, created opportunities, and served as a role model for women at every level of business – not just at Disney, but around the world,” Iger said.

Shares of Walt Disney closed 0.53% higher on Thursday.

Read Next: Ross Gerber Explains Thursday’s Rally — ‘Market Is Saying No Recession…’

Total
0
Shares
Related Posts
Read More

This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape

PharmaCielo revealed its plans to acquire cannabis operations in Thailand.On Wednesday, the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., said it has signed a binding letter of intent to enter a proposed transaction to acquire 100% of the issued and outstanding shares of Siam Ventures Corporation in exchange for common shares of PharmaCielo equaling to CA$3 million ($2.2 million).PharmaCielo also revealed it's undertaking a non-brokered private placement of 9,090,909 units at CA$0.2 per unit. Under the deal, the sum will be payable on closing by way of the issuance of 13,636,363 PharmaCielo Shares to the Siam Ventures' shareholders on a pro-rata basis.

PCLOF